Budgetary impact (US$) of the scenarios evaluated and incremental costs (ranibizumab alone; bevacizumab alone), 2008–2011, Brazil.
收藏NIAID Data Ecosystem2026-03-09 收录
数据链接：
官方服务：
资源简介：
1 real = US$2.00. Budgetary impact (US$) of the scenarios evaluated and incremental costs (ranibizumab alone; bevacizumab alone), 2008–2011, Brazil.
创建时间：
2015-10-12
